INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
AJ

Aryeh Jason

DirectorCIK 0001376960

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 2
Max Insider Score41
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$125K
500 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    LIGAND PHARMACEUTICALS INCDirector · Dec 8, 2025
41
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL
$1.13M
4,500 sh
Jun 11, 2026
Jun 12, 2026
traded Jun 11, 2026
+1d
SEC FORM 4

Evidence

15
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
2,938 sh
Jun 5, 2026Jun 12, 2026
traded Jun 5, 2026
+7dSEC FORM 4

Evidence

15
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
836 sh
Jun 5, 2026Jun 12, 2026
traded Jun 5, 2026
+7dSEC FORM 4

Evidence

12
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$141K
2,034 sh
Dec 8, 2025Dec 8, 2025
traded Dec 8, 2025
+0dSEC FORM 4

Evidence

9
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
2,034 sh
Dec 8, 2025Dec 8, 2025
traded Dec 8, 2025
+0dSEC FORM 4

Evidence